MediTox s.r.o.

Main activities

Non clinical R & D related to ophthalmic diseases (chronic glaucoma), contact dermatitis, osteoarthritis, non-clinical development of vaccines (influenza, adenovirus, etc.), inflammatory bowel diseases, non-alcoholic steatohepatitis (NASH)

Comprehensive non-clinical and toxicological program for assessment of human/veterinary drugs, vaccines, biological products, medical devices and food/feed additives (EMA/ICH/VICH/FDA/ISO), chemical substances and preparations (ECHA)

Models of selected human diseases - chronic glaucoma, contact dermatitis, osteoarthritis, non-clinical development of vaccines, inflammatory bowel diseases, non-alcoholic steatohepatitis,…

Accredited breeding facility (CZ 02396)

MediTox s.r.o.

MediTox s.r.o. is a GLP-certified preclinical contract research organization offering a wide range of preclinical development services taking advantage of wealth of experience in variety of therapeutics areas, biotechnology, chemical and agrochemical industry and research collaboration with universities and research institutions.

MediTox R&D activities are pointed to collaborative scientific and research projects within international and national framework.

The strong points of MediTox ensure personalized and comprehensive contract research (one-stop-shop), high professional standard together with flexibility and competitive pricing.

We will attend following events:

BIO-EUROPE SPRING digital, March 22 – 23, 2021


Nordic Life Sciences Days digital, April 18 – 20, 2021

Nordic Life Science Days 2021

BIO International Convention digital, June 10 – 18, 2021

BIO International Convention 2021

Life Sciences Baltics 2021, September 21 – 23, 2021

Life Sciences Baltics 2021

CPhI Worldwide 2021, November 9 – 11, 2021

CPhI Worldwide 2021

BioFIT 2021, December 14 – 15, 2021

BioFIT 2021

MediTox s.r.o.

MediTox s.r.o.

MediTox s.r.o.